Sarita, Meldyn S.

HRN: 28-74-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/17/2026
03/24/2026
IV
50mg
TID
AMOEBIASES, INFECTIOUS DIARRHEA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: